| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |